Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: Cryopreservation

Artificial Organs

Volumn 28, Issue 2, 2004, Pages 182-188

  Kubo, Kentaro ^a   Kuroyanagi, Yoshimitsu ^a  

^a KITASATO UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Collagen; Cultured dermal substitute; Fibroblast; Hyaluronic acid; Vascular endothelial growth factor

Indexed keywords

CELL CULTURE; CELL ENGINEERING; CELL GROWTH; DIMETHYL SULFOXIDE; ENDOTHELIAL CELLS; FIBROBLASTS; GROWTH KINETICS; HYALURONIC ACID; ORGANIC ACIDS; ORGANIC SOLVENTS; THAWING;

CELL VIABILITY; CONDITION; CRYO-PRESERVATION; CULTURED DERMAL SUBSTITUTES; FETAL BOVINE SERUM; FIBROBLAST; MATRIX; SULPHOXIDE; TIME POINTS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

COLLAGEN;

ATELOCOLLAGEN; DIMETHYL SULFOXIDE; GLYCEROL; HYALURONIC ACID; RINGER LACTATE SOLUTION; VASCULOTROPIN; WATER;

ARTICLE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE RELEASE; DERMIS; FIBROBLAST; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; THAWING; TISSUE CULTURE;

BOVINAE; CICONIIFORMES;

EID: 1242326268     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2004.47219.x     Document Type: Article

References (27)

1. Cooper ML, Hansbrough JF, Spielvogel RL, et al. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 1991;12:243-8.
2. Hansbrough JF, Christine D, Hansbrough WB. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. J Burn Care Rehabil 1992;13:519-29.
3. Hansbrough JF, Cooper ML, Cohen R, et al. Evaluation of a biodegradable matrix containing cultured human fibroblasts as a dermal replacement beneath meshed skin grafts on athymic mice. Surgery 1992;111:438-46.
4. Gentzkow GD, Iwasaki SD, Hershon KS, et al. Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996;19:350-4.
5. Hansbrough JF, Mozingo DW, Kealey GP, et al. Clinical trials of a biosynthetic temporary skin replacement, Dermagraft-Transitional Coverage, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil 1997;18:43-51.
6. Hansbrough JF, Morgan J, Greenleaf G. Development of a temporary living skin replacement composed of human neonatal fibroblasts cultured in Biobrane, a synthetic dressing material. Surgery 1994;115:633-44.
7. Yamada N, Shioya N, Kuroyanagi Y. Evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix as a wound dressing. Scand J Plast Reconstr Surg 1995;29:211-9.
8. Tanaka M, Nakakita N, Kuroyanagi Y. Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test. J Biomater Sci Polymer Edn 1999;10:433-53.
9. Yamashita R, Kuroyanagi Y, Nakakita N, Uchinuma E, Shioya N. Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: preliminary clinical trials. Wounds 1999;11:34-44.
10. Yamada N, Uchinuma E, Kuroyanagi Y. Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix. Scand J Plast Reconstr Surg 1999;33:147-54.
11. Kuroyanagi Y, Yamada N, Yamashita R, Uchinuma E. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts. Artif Organs 2001;25:180-6.
12. Kubo K, Kuroyanagi Y. Spongy matrix of hyaluronic acid and collagen for cultured dermal substitute: evaluation in animal test. J Artif Organs 2003;6:64-70.
13. Kubo K, Kuroyanagi Y. Characterization of cultured dermal substitute composed of spongy matrix of hyaluronic acid and collagen combined with fibroblasts. J Artif Organs 2003; 6:138-44.
14. Balazs A, Holmgren HJ. The basic dye-uptake and the presence of growth inhibiting substance in the healing tissue of skin wounds. Exp Cell Res 1950;1:206-16.
15. Culp LA, Murray BA, Rollins BJ. Fibronectin and proteoglycans as determinants of cell-substratum adhesion. J Supramol Struct 1979;11:401-27.
16. Lark MW, Laterra J, Culp LA. Close and focal contact adhesion s of fibroblasts to fibronectin-containing matrix. Fed Proc 1985;44:394-403.
17. Rollins BJ, Culp LA. Glycosaminoglycans in the substrate adhesion sites of normal and virus-transformed murine cells. Biochemistry 1979;18:141-8.
18. Tomida M, Koyama H, Ono T. Hyaluronic acid synthetase in culture mammalian cells producing hyaluronic acid. Oscillatory change during the growth phase and suppression by 5-bromodeoxyuridine. Biochim Biophys Acta 1974;338:352-63.
19. Benedetti L, Cortivo R, Berti T, Berti A, Pea F. Hyaluronic acid synthetase in culture mammalian cells producing hyaluronic acid. Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats. Biomater 1993;14:1154-8.
20. Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci USA 1978; 75:871-5.
21. Peter TD, Kenneth KI. Growth factors for wound healing. Biotechnology 1989;7:793-9.
22. Nissen NN, Polverini PJ, Koch AE, et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998;152:1445-52.
23. Ferrara N, Henzel WJ. Pituitary follicular cell secrete a novel heparin-binding growth factor specific vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-8.
24. Kumar R, Yoneda J, Fidler IJ. Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int J Oncol 1998;12:749-57.
25. Teasdale B, Sieber VK, Riches DJ, Nanchahal J. Cryopreservation of cultured dermal fibroblast impregnated collagen gels. Burns 1993;19:406-10.
26. Kearney JN. Cryopreservation of cultured skin cells. Burns 1991;17:380-3.
27. Kearney JN, Wheldon LA, Gowland G. Effects of cryobiological variables on the survival of skin using a defined murine model. Cryobiology 1990;27:164-70.